ReNeuron Group (RENE) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Mar 2019 02:30 PM
RNS
Notification of Major Holdings
05 Mar 2019 12:56 PM
RNS
Notification of Major Holdings
05 Mar 2019 07:00 AM
RNS
Notification of Major Holdings
05 Mar 2019 07:00 AM
RNS
Notification of Major Holdings
28 Feb 2019 07:00 AM
RNS
Block Listing Review and Total Voting Rights
20 Feb 2019 07:00 AM
RNS
Positive preliminary data in US retinal trial
31 Jan 2019 07:00 AM
RNS
New exosome production scale-up data presented
24 Jan 2019 07:00 AM
RNS
First patient treated in US stroke trial
04 Jan 2019 07:00 AM
RNS
ReNeuron signs exosome collaboration
14 Dec 2018 07:00 AM
RNS
Interim Results
20 Nov 2018 02:00 PM
RNS
Notification of Interim Results
18 Oct 2018 07:00 AM
RNS
ReNeuron's lead cell line shows further potential
28 Sep 2018 02:16 PM
RNS
Director/PDMR Interest in Shares and Share Options
27 Sep 2018 03:02 PM
RNS
Directors Share Purchases
19 Sep 2018 04:40 PM
RNS
Second Price Monitoring Extn
19 Sep 2018 04:35 PM
RNS
Price Monitoring Extension
19 Sep 2018 07:00 AM
RNS
Business development update
12 Sep 2018 11:40 AM
RNS
Result of AGM
12 Sep 2018 07:00 AM
RNS
AGM Trading Update
31 Aug 2018 07:00 AM
RNS
Block Listing Review and TVR
31 Jul 2018 03:25 PM
RNS
Posting of Annual Report & Notice of AGM
17 Jul 2018 07:00 AM
RNS
Notification of Major Holdings
16 Jul 2018 03:39 PM
RNS
Notification of Major Holdings
16 Jul 2018 07:00 AM
RNS
Notification of Major Holdings
13 Jul 2018 11:50 AM
RNS
Notification of Major Holdings
12 Jul 2018 07:00 AM
RNS
Preliminary Results
11 Jul 2018 07:00 AM
RNS
Signs retinal stem cell exclusivity agreement
04 Jul 2018 02:15 PM
RNS
Notification of Preliminary Results
17 May 2018 07:00 AM
RNS
Capital Markets Event
04 May 2018 07:00 AM
RNS
Exosome data presented at ISCT conference
30 Apr 2018 07:00 AM
RNS
Capital Markets Event and Webcast
19 Apr 2018 07:00 AM
RNS
Wins grant for retinal cell therapy development
10 Apr 2018 01:00 PM
RNS
Appointment of US-based Chief Medical Officer
26 Mar 2018 07:00 AM
RNS
Product Development Update
01 Mar 2018 07:00 AM
RNS
Block Listing Review and TVR
16 Feb 2018 07:00 AM
RNS
Block Listing Application
13 Feb 2018 10:00 AM
RNS
Positive pre-clinical data in nerve injury
26 Jan 2018 07:00 AM
RNS
Phase II stroke data presented at AHA conference
23 Jan 2018 11:06 AM
RNS
Approval of Share Capital Reorganisation
11 Jan 2018 07:00 AM
RNS
Further re Share Capital Reorganisation
05 Jan 2018 07:00 AM
RNS
Proposed Share Capital Reorganisation
14 Dec 2017 07:00 AM
RNS
Interim results
14 Dec 2017 07:00 AM
RNS
Stroke clinical trial regulatory approval in US
08 Dec 2017 07:00 AM
RNS
ReNeuron opens US office
13 Nov 2017 11:30 AM
RNS
Notification of Interim Results
08 Nov 2017 07:00 AM
RNS
Retinal disease clinical trial moves into Phase II
31 Oct 2017 07:00 AM
RNS
Positive stroke clinical data & regulatory update
27 Oct 2017 07:00 AM
RNS
Wins further UK grant
11 Oct 2017 01:31 PM
RNS
PDMR Interest in Shares and Share Options
09 Oct 2017 07:00 AM
RNS
Presentation of positive pre-clinical data
UK 100

Latest directors dealings